FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and pharmaceutical industry and deals with solution of high-efficient composition in form of solution of active and additional substances, which makes it possible to form aerosol of small particles aimed at penetration in bronchi and pulmonary alveoli. Solution for obtaining medication for inhalational introduction contains fenoterol hydrobromide and ipratropium bromide as active substances, and sodium benzoate, food organic acid, purified water as additional substances with specified ratio of components.
EFFECT: solution has high value of respirable fractions.
6 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
IPRATROPIUM BROMIDE SOLUTION | 2012 |
|
RU2496477C1 |
STABLE SOLUTION OF FENOTEROL HYDROBROMIDE | 2012 |
|
RU2479304C1 |
COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
AEROSOL PREPARATION BASED ON FENOTEROL HYDROBROMIDE FOR TREATING RESPIRATORY DISEASES | 2015 |
|
RU2577289C1 |
AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
PHARMACEUTICAL INHALED MEDICATION FOR TREATMENT OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE LUNG DISEASE, CONTAINING MICRONISED TIOTROPIUM BROMIDE AS ACTIVE SUBSTANCE AND METHOD OF ITS PRODUCTION | 2012 |
|
RU2522213C2 |
INHALATION PREPARATION FOR TREATING BRONCHAIL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2504382C1 |
INHALATION PREPARATION FOR TREATING RESPIRATORY DISEASES CONTAINING MICRONISED SALMETEROL XINAFOATE AND MICRONISED FLUTICASONE PROPIONATE AS ACTIVE SUBSTANCES AND METHOD FOR PREPARING IT | 2012 |
|
RU2494730C1 |
INHALATION PREPARATION FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND METHOD FOR PREPARING IT | 2012 |
|
RU2510267C2 |
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
Authors
Dates
2013-09-27—Published
2012-10-03—Filed